FINWIRES · TerminalLIVE
FINWIRES

Research Alert: CFRA Lifts Opinion On Shares Of Enphase Energy, Inc. To Hold From Sell

作者

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lower our target by $5 to $35, or 17.5x our 2026 EPS view. This is below ENPH's five-year average (~27x) given weak solar demand and regulatory headwinds. We lower our 2026 EPS by $0.31 to $2.00 and 2027's by $0.31 to $2.40. U.S. solar demand continues to worsen, with sell-through for Q1 and Q2 (expected) coming in approximately 15% below management's initial expectations for the year. We think regulatory frictions are playing a role as residential customers switch to the TPO model, and these headwinds will likely persist in the near term. However, we expect the TPO model to gain traction by 2027 as homeowners grow comfortable with the new offerings. Meanwhile, we expect improving battery demand in Europe, where activations are already improving across several markets and the Strait of Hormuz closure is amplifying resilience concerns. We also see longer-term upside from ENPH's new data center-focused platform (IQ SSTs), with revenues likely to materialize in 2028, despite the highly competitive landscape.

相關文章

Insider Trading

根據最近提交給美國證券交易委員會(SEC)的文件顯示,Kratos Defense & Security Solutions 的一名內部人士出售了價值 431,451 美元的股票。

美國分部總裁史蒂文·S·芬德利 (Steven S. Fendley) 於 2026 年 4 月 27 日出售了 Kratos Defense & Security Solutions (KTOS) 的 7,000 股股票,套現 431,451 美元。根據向美國證券交易委員會 (SEC) 提交的 4 號表格文件,芬德利目前控制著該公司共計 351,039 股普通股,其中 351,039 股為他直接持有。 SEC 文件連結: https://www.sec.gov/Archives/edgar/data/1069258/000169543426000006/xslF345X05/primary_doc.xml

$KTOS
Commodities

Antero Midstream 第一季集氣量成長 14%

Antero Midstream (AM) 公佈,2026 年第一季天然氣收集量有所增長,但其他營運指標與去年同期相比表現不一。 該公司表示,天然氣收集量成長 14%,達到每日 38.05 億立方英尺,高於 2025 年第一季的 33.48 億立方英尺/日。 集中壓縮處理量小幅成長 1%,每日 33.7 億立方英尺,高於去年同期的 33.3 億立方英尺/日。 淡水輸送量下降 21%,至每日 8.3 萬桶,低於去年同期的 10.5 萬桶/日。 同時,合資企業天然氣加工量成長 4%,從每日 16.5 億立方英尺增至每日 17.08 億立方英尺。合資企業分餾處理量維持不變,每日 4 萬桶。

$AM
Insider Trading

根據最近提交給美國證券交易委員會(SEC)的文件顯示,Revolution Medicines公司內部人士出售了價值413,129美元的股票。

2026年4月27日,全球首席商業化長安東尼·曼奇尼(Anthony Mancini)出售了Revolution Medicines (RVMD)的3,120股股票,套現413,129美元。根據向美國證券交易委員會(SEC)提交的4號表格文件,曼奇尼目前持有該公司54,400股普通股,其中54,400股為直接持有。 SEC文件連結: https://www.sec.gov/Archives/edgar/data/1628171/000161071726000158/xslF345X05/form4.xml

$RVMD